RECENT POST
Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).
RECENT POST
Apr 25, 2022 6:25:12 AM |
Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).
Broker Dealer Services
Provided Through Covington Associates, LLC. Member FINRA/SIPC.
© 2017 Covington Associates All Rights Reserved.